FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Clinitech Laboratory IPO and Macobs Technologies IPO.
Clinitech Laboratory IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Macobs Technologies IPO is a SME Book Built Issue proposed to list at NSE SME.
Clinitech Laboratory IPO | Macobs Technologies IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Book Built Issue |
Listing At | BSE SME | NSE SME |
Lead Managers | Inventure Merchant Banker Services Pvt Ltd | SKI Capital Services Limited |
Registrar | Bigshare Services Pvt Ltd | Maashitla Securities Private Limited |
Market Maker | Svcm Securities Private Limited | SKI Capital Services Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Clinitech Laboratory IPO is up to ₹5.78 Cr whereas the issue size of the Macobs Technologies IPO is up to ₹19.46 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of Macobs Technologies IPO is ₹75.00 per share.
Clinitech Laboratory IPO | Macobs Technologies IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹71.00 per share | |
Issue Price (Upper) | ₹75.00 per share | |
Issue Price (Final) | ₹96.00 per share | ₹75.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1200 shares | 1600 shares |
Fresh Issue Size | 6,02,400 shares | 25,95,200 shares |
Fresh Issue Size (Amount) | up to ₹5.78 Cr | up to ₹19.46 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 6,02,400 shares | 25,95,200 shares |
Issue Size Total (Amount) | up to ₹5.78 Cr | up to ₹19.46 Cr |
Clinitech Laboratory IPO opens on Jul 25, 2024, while Macobs Technologies IPO opens on Jul 16, 2024. The closing date of Clinitech Laboratory IPO and Macobs Technologies IPO is Jul 29, 2024, and Jul 19, 2024, respectively.
Clinitech Laboratory IPO | Macobs Technologies IPO | |
---|---|---|
Anchor Bid Date | Jul 15, 2024 | |
Issue Open | Jul 25, 2024 | Jul 16, 2024 |
Issue Close | Jul 29, 2024 | Jul 19, 2024 |
Basis Of Allotment (Tentative) | Jul 30, 2024 | Jul 22, 2024 |
Initiation of Refunds (Tentative) | Jul 31, 2024 | Jul 23, 2024 |
Credit of Share (Tentative) | Jul 31, 2024 | Jul 23, 2024 |
Listing date (Tentative) | Aug 01, 2024 | Jul 24, 2024 |
Anchor Lockin End date 1 | Aug 21, 2024 | |
Anchor Lockin End date 2 | Oct 20, 2024 |
Clinitech Laboratory IPO P/E ratio is 43.45, as compared to Macobs Technologies IPO P/E ratio of 24.4.
Clinitech Laboratory IPO | Macobs Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Clinitech Laboratory Limited Financial Information (Restated)Clinitech Laboratory Limited's revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Macobs Technologies Limited Financial Information (Restated)Macobs Technologies Limited's revenue increased by 39.91% and profit after tax (PAT) rose by 8.2% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 83.63% | 65% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 61.56% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 43.45 | 24.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹21.91 Cr. | ₹73.46 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 36.06%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 30.53%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹2.21 | ₹3.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 10.46%% | 22.52%% |
In the Clinitech Laboratory IPO retail investors (RII) are offered 3,01,200 shares while in Macobs Technologies IPO retail investors are offered 3,01,200 shares. Qualified institutional buyers (QIB) are offered 0 shares in Clinitech Laboratory IPO and 2,96,000 shares in Macobs Technologies IPO.
Clinitech Laboratory IPO | Macobs Technologies IPO | |
---|---|---|
Anchor Investor Reserveration | 4,43,200 shares | |
Market Maker Reserveration | 31,200 shares | 1,31,200 shares |
QIB | 0 shares | 2,96,000 shares |
NII | 3,01,200 shares | 8,62,400 shares |
RII | 3,01,200 shares | 8,62,400 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 5,71,200 shares | 20,20,800 shares |
Clinitech Laboratory IPO subscribed 38.96x in total, whereas Macobs Technologies IPO subscribed 202.32x.
Clinitech Laboratory IPO | Macobs Technologies IPO | |
---|---|---|
QIB (times) | 88.92x | |
NII (times) | 23.28x | 266.70x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 49.61x | 176.87x |
Employee (times) | ||
Other (times) | ||
Total (times) | 38.96x | 202.32x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|